1. Lu M, Adamis AP. Molecular biology of choroidal neovascularization. Ophthalmol Clin North Am. 2006; 19:323–34.
2. Sun JK, Miller JW. Medical treatment of choroidal neovascularization secondary to age-related macular degeneration. Int Ophthalmol Clin. 2005; 45:115–32.
Article
3. Rakic JM, Lambert V, Munaut C. . Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003; 44:1732–9.
Article
4. Heiligenhaus A, Li HF, Yang Y. . Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. Invest Ophthalmol Vis Sci. 2005; 46:4079–85.
Article
5. Lee JH, Lee HK, Kim JK. . Expression of laminin-5 with amniotic membrane transplantation in excimer laser ablated rat corneas. J Cataract Refract Surg. 2004; 30:2192–9.
Article
6. Saw VP, Minassian D, Dart J. . Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group. Br J Ophthalmol. 2007; 91:1042–7.
Article
7. Shao C, Sima J, Zhang SX. . Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci. 2004; 45:1758–62.
Article
8. Takahashi H, Igarashi T, Fujimoto C. . Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. Jpn J Ophthalmol. 2007; 51:3–9.
Article
9. Kiilgaard JF, Prause JU, Prause M. . Subretinal posterior pole injury induces selective proliferation of RPE cells in the periphery in in vivo studies in pigs. Invest Ophthalmol Vis Sci. 2007; 48:355–60.
Article
10. Lassota N, Kiilgaard JF, Prause JU, la Cour M. Correlation between clinical and histological features in a pig model of choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2006; 244:394–8.
Article
11. Lee MS, Lee KM, Kim SH, Kwon OW. Adhesion between amniotic membrane and retinal tissue and inhibition of amniotic membrane on cell transformation. J Korean Ophthalmol Soc. 2003; 44:459–71.
12. Koh HJ, Bessho K, Cheng L. . Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6. Invest Ophthalmol Vis Sci. 2004; 45:635–40.
Article
13. Campochiaro PA. Ocular neovascularisation and excessive vascular permeability. Expert Opin Biol Ther. 2004; 4:1395–402.
Article
14. Kobayashi N, Kabuyama Y, Sasaki S. . Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002; 21:62–7.
Article
15. Ha HS, Song KY, Kim JC. Ultrastructural Analysis of in vivo Expanded Corneal Epithelium on Amniotic Membrane. J Korean Med Sci. 2006; 21:544–9.
Article
16. Kim MK, Lee JL, Wee WR. Lee JH. Adhesion complex in cultivated limbal epithelium on amniotic membrane after transplantation into chemical burn model. J Korean Ophthalmol Soc. 2004; 45:1731–41.
17. Park GS, Je J, Kim JC. Stepwise surgical approach for in vivo expansion of epithelial stem cells to treating severe acute chemical burns with total limbal deficiency. Korean J Ophthalmol. 2003; 17:75–82.
18. Alviano F, Fossati V, Marchionni C. . Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007; 7:11.
Article
19. Cheung CY, Brace RA. Developmental expression of vascular endothelial growth factor and its receptors in ovine placenta and fetal membranes. J Soc Gynecol Investig. 1999; 6:179–85.
Article